Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-07-14
2008-08-12
Aulakh, Charanjit S (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S017000, C544S124000, C544S333000, C544S360000, C514S232800, C514S253030, C514S256000
Reexamination Certificate
active
07410976
ABSTRACT:
The invention relates to a compound of a formula (I):or a pharmaceutically acceptable salt or ester thereof, useful as a therapeutic agent for various ACC-related disorders.
REFERENCES:
patent: 5206240 (1993-04-01), Baldwin et al.
patent: 5633247 (1997-05-01), Baldwin et al.
patent: 5885999 (1999-03-01), Elliott et al.
patent: 004624 (1979-03-01), None
patent: 2005-119987 (2005-12-01), None
patent: WO 94/17045 (1994-08-01), None
patent: WO 95/30642 (1995-11-01), None
patent: WO 96/39140 (1996-12-01), None
patent: WO 2004/092179 (2004-10-01), None
patent: WO 2006/055752 (2006-05-01), None
Database Chemcats Abstract XP002407688, CAS-registry No.: 877811-12-6, 877811-11-5 & “Interchim Intermediates”, Jan. 18, 2005.
Iino Tomoharu
Imamura Hideaki
Jona Hideki
Kusunoki Jun
Niiyama Kenji
Aulakh Charanjit S
Fair Janet E.
Fitch Catherine D.
Merck & Co. , Inc.
LandOfFree
Spirochromanone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Spirochromanone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spirochromanone derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4017418